Nanoconjugate Strategy Integrating Immunogenic Cell Death Induction and Innate Immune Activation for Potent Anti-Cancer Immunity.
In vivo immune modulation can potentially benefit broader cancer patients. Efficient cross-priming of anti-tumor T cells requires "three-signal" dendritic cells (DCs) that simultaneously integrate antigenic, co-stimulatory, and migratory programs, which remains a major challenge. Here, we developed a carrier-free pepti...